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Abstract
Purpose: To evaluate the indications and efÀ cacy of high gas permeable scleral contact lenses 
(GP-SCL).
Methods: A total database of 97 consecutive patients (140 eyes) À tted with GP-SCL between 
January 2003 and December 2008, was retrospectively analyzed to determine the beneÀ ts of 
À tting scleral lenses. All lenses were À tted by preformed technique and were non-fenestrated. 
Patients included keratoconus - 88 eyes (63 %); corneal irregularities after penetrating 
keratoplasty - 39 eyes (28 %); various ocular surface disorders: Stevens-Johnson syndrome (SJS), 
graft versus host disease (GVHD) and exposure keratopathy - 6 eyes (4 %); post refractive surgery 
keratoectasia - 4 eyes (3 %), and high refractive error - 3 eyes (2 %).
Results: Mean follow up was 27.5 months (range 1-71), mean wearing time in successful wearers 
group was 12.2 hours per day (range 10-16), mean wearing time in group of wearers who dropped 
out using GP-SCL, was 5.8 hours (range 3-8). Keratoconus patients achieved median best corrected 
visual acuity (BCVA) of 20/32, 84 % of patients achieved BCVA of 20/40 or more. The post 
keratoplasty group achieved median BCVA of 20/25, 92 % of patients achieved BCVA of 20/40 or 
better. In the other groups, median BCVA was as follows: ocular surface disorders - 20/50, 
keratoectasia - 20/30, high refractive error - 20/32. Positive Á uid-venting was highly associated 
with successful GP-SCL wearing. Twenty patients (21 %) failed to wear GP-SCL.
Conclusions: GP-SCL’s expand the management of various corneal abnormalities. The main 
indication for GP-SCL is optical correction of an irregular corneal surface, especially keratoconus 
and corneal transplant.
© 2010 Spanish General Council of Optometry. Published by Elsevier España, S.L. All rights reserved.
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Aplicaciones actuales y eÀ cacia de las lentes de contacto esclerales: 
un estudio retrospectivo
Resumen
Objetivos: Evaluar las indicaciones y eÀ cacia de las lentes de contacto esclerales de alta per-
meabilidad al gas (LCE-PG).
Métodos: Se analizó de forma retrospectiva una base de datos con un total de 97 pacientes conse-
cutivos (140 ojos) que fueron prescritos LCE-PG entre enero 2003 y diciembre 2008, para determi-
nar los beneÀ cios de llevar lentes esclerales. Todas las lentes fueron adaptadas mediante técnica 
preformada y no estaban fenestras. Entre los pacientes, había 88 (63 %) ojos queratoconos; 39 ojos 
(28 %) con irregularidades corneales después de queratoplastia penetrante; diversos trastornos 
superÀ ciales oculares: síndrome de Stevens-Johnson (SSJ), enfermedad injerto contra huésped 
(GVHD, en inglés) y 6 ojos (4 %) con queratopatía por exposición; 4 ojos (3 %) con queratectasia 
tras cirugía refractiva, y 3 ojos (2 %) con elevado defecto refractivo.
Resultados: El seguimiento medio fue de 27,5 meses (intervalo 1-71), el tiempo medio de uso en 
el grupo que se adaptó con éxito a las LCE-PG fue de 12,2 horas por día (intervalo 10-16), la media 
de uso en el grupo que las abandonó fue de 5,8 horas (intervalo 3-8). Los pacientes con querato-
cono lograron una mediana de mejor agudeza visual corregida (BCVA, en inglés) de 20/32, el 84 % 
de los pacientes lograron una BCVA de 20/40 o superior. El grupo de posqueratoplastia logró una 
BCVA mediana de 20/25, el 92 % de los pacientes lograron una BCVA de 20/40 o superior. En los 
otros grupos, la BCVA mediana fue la siguiente: trastornos oculares superÀ ciales: 20/50; queratec-
tasia: 20/30, defecto refractario alto: 20/32. La ventilación de Á uido positiva estaba altamente 
asociada con una adaptación exitosa a las LCE-PG. Veinte pacientes (21 %) no lograron usar las 
LCE-PG.
Conclusiones: Las LCE-PG amplían las posibilidades de tratamiento de diversas anormalidades 
corneales. La indicación principal para las LCE-PG es la corrección óptica de una superÀ cie corneal 
irregular, especialmente en queratocono y trasplante corneal.
© 2010 Spanish General Council of Optometry. Publicado por Elsevier España, S.L. Todos los derechos 
reservados.
Introduction
Thousands of people all over the world are considered 
legally blind or have very poor vision due to keratoconus, 
high or irregular astigmatism and other forms of corneal 
irregularities or dystrophies.
The concept of optically neutralizing the cornea with 
a lens which enclosed a liquid reservoir over the corneal 
front surface was proposed in 1508 by Leonardo da Vinci. 1 
Almost 400 years later Fick 2 designed the earliest practical 
contact lenses, which were scleral lenses. His idea was to 
neutralize the optical effects of the corneal distortion for 
patients with irregular astigmatism by using afocal scleral 
glass shells.
Modern scleral lenses are indicated for several ocular 
conditions such as keratoconus and other primary corneal 
ectasia, post corneal transplant when residual high refractive 
error exists or the surface remains highly irregular, serious 
dry eye conditions and neurotrophic keratitis, and can 
nearly always be À tted successfully. 3-5 These lenses offer 
two unique advantages.
Firstly, they are supported by the sclera and therefore can 
be À tted on eyes with markedly irregular corneas. This is 
particularly important for patients with corneal irregularity, 
when vision cannot be improved with rigid corneal contact 
lenses, either because of the patients’ poor tolerance level 
or inability to À t such a lens.
Secondly, there is the constant aqueous reservoir 
between the lens and the cornea. This reservoir neutralizes 
most of the irregular astigmatism and protects the corneal 
surface from the desiccating effects of exposure to air 
and the friction of blinking. This is especially important in 
cases of non-healing corneal epithelial defects and other 
ocular surface diseases that cannot be resolved with other 
currently available therapeutic modalities.
Until the last decade of the past century, these 
advantages could not be fully realized because of chronic 
corneal hypoxia attributed to low gaseous permeability of 
polymethyl methacrylate (PMMA) and other materials from 
which the lenses were made. 6-8
The development of rigid gas-permeable plastics greatly 
reduced the hypoxic complications associated with daily 
wear of corneal lenses and added a new dimension to the 
potential of scleral lenses for the visual rehabilitation of 
patients with markedly irregular corneas and treatment of 
ocular surface disorders. In 1983 Ezekiel 9 described the use 
of preformed, fenestrated, silicone/acrylate gas permeable 
scleral contact lenses in À tting patients with keratoconus, 
severe myopia, aphakia, and corneal scarring. Since then, 
new techniques in the manufacture of rigid gas-permeable 
scleral lenses have been developed. 10-12
In this article, we will report our experience in fitting 
patients with sealed non-fenestrated GP-SCL and assess 
the vision rehabilitation and therapeutic benefits in 
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the management of various corneal and ocular surface 
diseases.
Methods
Clinical data from the records of 97 consecutive patients 
(140 eyes), À tted with GP-SCL between January 2003 and 
December 2008, were retrospectively analyzed to determine 
the indications for lens À tting and visual outcomes.
Patients were referred to the contact lens clinic in Hadassah 
University Hospital, due to severe corneal irregularities or 
corneal surface disorders resistant to other therapeutic 
options. Patients referred for vision rehabilitation were unable 
to wear corneal rigid gas permeable (RGP) lenses or À tting of 
such lenses was contraindicated. Ocular pathologies included: 
keratoconus, keratoglobus and pellucid marginal degeneration 
(KC), corneal irregularity after penetrating keratoplasty (PKP), 
severe exposure keratopathy, Stevens-Johnson syndrome 
(SJS), graft versus host disease (GVHD) or other ocular surface 
disorders (OSD), corneal ectasia after refractive surgery and 
high refractive errors (HRE).
GP-SCL features
The lenses were lathed by City Crown Aspheric 7 CNC lathe 
(Microlens Ltd. Tel Aviv). Two highly gas permeable polymers 
were used: TYRO-97 (Lagado Corp.) having a permeability Dk 
value of 97 × 10—11 cm 2 mL O2/sec mL mm Hg (International 
Organization for Standardization [ISO]/Fatt) and Optimum 
Extreme (Contamac corp.) Dk value of 125 × 10—11 cm 2 mL 
O2/sec mL mm Hg (ISO/Fatt) units.
Use of hyper-Dk/t RGP lens materials (> 100 Dk/t) have 
been shown to supply enough oxygen to the cornea in all day 
lens wearers, which does not compromise corneal health in 
terms of increased corneal swelling. 13
Each sleral lens was preformed, non-fenestrated and 
sealed, with an overall diameter of 18.5 mm, designed to 
barely clear the highest point of the cornea and to provide 
the most uniform thickness proÀ le of the Á uid accumulated 
between the lens and the cornea. By maintaining the 
minimal thickness of this reservoir, we optimized the oxygen 
transmissibility of the lens-cornea system and minimized 
the degradation of vision that occurs if excessive tear 
debris accumulate inside this reservoir during lens wear. 
The thickness of this proÀ le ranged between one third of 
corneal thickness and 300-400 mm. The curvature of the 
central back surface of each lens (optic zone) was chosen to 
maintain a shallow, but deÀ nite clearance of the cornea and 
limbus, thus the lens was entirely supported by the sclera. 
Corneal clearance was evaluated by slit lamp examination 
to establish the optimal sagittal height of each lens.
In an average lens, the internal optic zone of 12.5 mm was 
a single curve surrounded by a 1.5-2.0 mm wide transitional 
zone vaulting the limbus and merging seamlessly into the 
posterior haptic surface (Figure 1). The haptic parameters of 
individual lenses were determined by observing the vascular 
compression patterns of the bulbar conjunctiva, using a 
series of diagnostic lenses of different haptic designs aimed 
at minimizing lens induced compression of conjunctival 
blood vessels and enabling unobstructed blood circulation. 
The average center thickness of the lenses was 0.35 mm.
Fluorescein Á uid-venting test
After the lens had been placed on the eye with sterile saline 
and had been in position for at least 2 hours, Á uorescein dye 
was installed. After 5 minutes, a slit lamp examination with 
cobalt blue À lter or optic section was performed. 4,5,14 In cases 
when Á uorescein diffused under the lens haptic and reached 
the pre-corneal liquid chamber independently or by gentle 
palpation, the test was considered positive (Figure 2) if no 
Á uorescence was seen – the test was considered negative.
Indications for success/failure
We considered the À tting of GP-SCL to be successful when 
wearing time of 10 hours a day or more, with no lens 
adhesion on removal, was reached. Partial success was 
deÀ ned as ability to wear the lenses between 6 to 10 hours 
a day. Wearing of GP-SCL less then 6 hours a day was 
considered to be a failure.
Results
A total of 97 patients (140 eyes) included 29 females (30 %) 
and 68 males (70 %), the patients’ ages ranged between 
16-77 years. Mean follow up was 27.5 months (range 1-71).
Indications
The primary clinical indications for GP-SCL could be 
categorized in three main categories: vision improvement 
Corneal 
clearance
Optical zone
Haptic surface
Sclera
Cornea
Transitional
zone
Figure 1 Fitting relationship of the scleral contact lens.
Figure 2 Fluorescein dye diffusion under the GP-SCL haptic 
into pre-corneal Á uid reservoir.
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(134 eyes), management of severe ocular surface disease 
and corneal protection (6 eyes), and multiple indications 
that include both vision improvement and corneal protection 
(10 eyes).
The most common diagnoses for use of GP-SCL was 
keratoconus (KC) - 88 eyes (63 %), followed by extreme 
corneal irregularities or high astigmatism after penetrating 
keratoplasty (PKP) - 39 eyes (28 %). Other indications 
included various ocular surface disorders (OSD) - 6 eyes 
(4 %): 2 eyes with corneal stem cell disorder (Steven-Johnson 
syndrome), 2 eyes with severe dry eye syndrome due to 
GVHD, 1 eye was treated for severe exposure keratopathy 
and 1 eye had post herpetic keratitis.
Four eyes (3 %) were À tted with GP-SCL for post refractive 
surgery keratoectasia (2 eyes PRK, 2 eyes LASIK); 3 eyes (2 %) 
fitted due to high refractive errors: 2 eyes were aphakic 
and 1 eye had high myopia with spherical equivalent of 
—16.00 diopter.
EfÀ cacy
Eighty eight of the 134 eyes that were À tted primarily to 
improve vision had keratoconus. Another 39 eyes were 
À tted due to inadequate spectacle-corrected vision after 
successful penetrating keratoplasty. Some of those eyes 
had undergone multiple unsuccessful surgical procedures 
for reducing the iatrogenic astigmatism. In most of these 
cases, the scleral lens provided useful corrected vision, 
regardless of the amount or type of corneal astigmatism 
present.
Median visual acuity (VA) with GP-SCL was 20/32 (Snellen 
fraction) and ranged from 20/400 to 20/20. The median best 
spectacle corrected VA without a contact lens was 20/70 
(range 20/800-20/30). There was a signiÀ cant increase in VA 
with scleral lenses compared to the best spectacle corrected 
VA (P < 0.001, signed rank test).
Improvement in best-corrected visual acuity (BCVA), 
deÀ ned as a gain of two or more decimal acuity lines, was 
observed in 125 eyes (93 %) out of the 134 eyes treated for 
vision improvement.
Visual outcomes varied according to the preexisting 
ocular status. The best visual results were obtained in the 
post PKP group, which achieved 20/40 or more in 92 % of 
cases with median BCVA of 20/25. Eyes in the keratoconus 
group achieved 20/40 or more in 84 % of cases with 
median BCVA of 20/32. In other groups, median BCVA was 
as follows: OSD 20/50, keratoectasia 20/30, HRE 20/32 
(Table 1).
During the period of study 102 eyes (73 %) were successfully 
À tted, as deÀ ned by success criteria, i.e. able to wear the 
lenses for more than 10 hours a day, and 15 eyes (11 %) 
achieved partial success with GP-SCL. Mean wearing time of 
successful wearers was 12.2 hours a day (range 10-16). The 
mean wearing time among all À tted patients was 11 hours a 
day (ranged 5-16). Wearing times of the treated groups are 
shown in Figure 3.
Seventy eight eyes (77 %) in the successful wearers group 
had positive Á uorescein dye test (Table 2). Fluorescein dye 
penetration under the lens haptic, i.e. positive Á uid-venting 
was highly associated with successful GP-SCL wearing, 
(P = 0.0007, chi-square test)
Twenty patients (21 %) failed to wear GP-SCL. Mean 
wearing time in this group was 5.8 hours a day (range 3-8) 
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Figure 3 Daily wearing time among GP-SCL users.
Table 1 Best visual acuity and average wearing time achieved with GP-SCL À tted for various conditions and range
 N (%)  20/40 < 20/40 to 
 20/200
< 20/200 Mean wearing time 
in hours (range)
KC 88 (63) 74 (53) 14 (10) 0 (—) 11.9 (5-16)
Post-PKP 39 (28) 36 (26) 3 (2) 0 (—) 12.2 (8-16)
OSD 6 (4) 2 (1.5) 3 (2) 1 (1) 9.3 (5-14)
Others 7 (5) 3 (2) 4 (3) 0 (—) 9.1 (6-12)
Total 140 (100.0) 115 (82) 24 (17) 1 (1) 11 (5-16)
KC: keratoconus; OSD: ocular surface disease; PKP: penetrating keratoplasty.
Table 2 Fluorescein Á uid-venting in successful and failed 
wearers
 Successful Failed Total
Positive Á uorescein test  78 (56 %) 17 (12 %) 95 (68 %)
Negative Á uorescein test  24 (17 %) 21 (15 %) 45 (32 %)
Total 102 (73 %) 38 (27 %) 140 (100 %)
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and mean drop-out period was 5.1 month. Seven successfully 
fitted patients (7 %) dropped-out wearing GP-SCL due to 
further penetrating keratoplasty procedure (mean follow up 
16.8 month).
Discussion
This retrospective review shows that medical applications 
of GP-SCL include both visual and therapeutic uses for a 
range of complicated corneal and ocular surface conditions 
for which treatment by other methods is either unsuitable 
or less effective.
Diagnoses may be categorized into four main groups: 
primary or induced keratoectasia, post penetrating 
keratoplasty, ocular surface diseases and high refractive 
errors. In the current study, patients with keratoconus and 
other forms of irregular corneal surface formed the largest 
group (63 %), followed by post penetrating keratoplasty 
iatrogenic astigmatism group (28 %), and ocular surface 
disorders group (4 %).
Vision improvement was the primary indication for GP-SCL 
in nearly 95 % of the À tted eyes, and was achieved in most 
instances by neutralizing the corneal irregularities or 
correcting existing refractive errors.
Visual outcomes varied according to the preexisting ocular 
status. The best visual results were obtained in the post 
keratoplasty group, which achieved 20/40 or better in 92 % 
of cases. These patients were À tted with GP-SCL to correct 
post PKP corneal astigmatism or corneal irregularities, 
induced by transplant misalignment.
The patients suffering from keratoconus had severe forms 
of the disease leading to failure with corneal contact lenses 
or were unable to tolerate wearing this type of lenses. 
They were À tted with GP-SCL as the last alternative before 
surgery. Visual outcomes obtained in this group showed 
signiÀ cant improvement of visual acuity, 20/40 or better in 
84 % of patients.
Keratoconus patients are commonly adolescents, and 
may require corneal surgery during their lifetime. The risks 
associated with the keratoplasty procedure, which include 
infection, rejection, and severe astigmatism, may be 
greater than those attributed to GP-SCL wear. 15
Comparison with previous studies
Various evaluation methods of GP-SCL performance 
demonstrate different results, thus it is difÀ cult to make 
direct comparisons between studies. Since the first 
successful application of gas-permeable scleral lenses by 
Ezekiel 9 in 1983, several studies have been published. The 
study designs varied in size, diagnoses, À tting methods, 
scleral lens types and materials. However, as in our study 
the most common indication was keratoconus, followed 
by post keratoplasty. 5,16-18 The large retrospective studies 
of Pullum and Buckley 16 and Rosenthal and Croteau 4 on 
530 and 538 patients, respectively, included a host of 
clinical indications but keratoconus and post penetrating 
keratoplasty still comprised the two largest groups. 
However in a study carried out in the early nineties, 
Tan et al. 19,20 reported keratoconus as the most common 
condition requiring scleral lenses followed by aphakia and 
then post keratoplasty. Lenses used varied greatly in size 
from 15 mm to 23mm. 4,5,18,21 Schornack and Patel 21 used a 
scleral lenses with an overall diameter of 18.2 mm, which 
is similar to the lenses used in our study (18.5 mm). They 
suggested that lenses that are supported by the sclera 
and clear both the cornea and limbus could be defined 
as ‘scleral’ lenses irrespective of the actual overall 
diameter.
The characteristics of our patients and our results were 
similar to those reported by other studies 5,18 regarding visual 
rehabilitation. Our study conÀ rmed the best acuity results 
achieved in patients with irregular or severe astigmatic 
topography. 5,16-18,20 Studies that included indications other 
than visual correction, treatment of ocular surface disease 
for example, showed less marked improvement in VA. 
The reason of lower visual results is primarily therapeutic 
indication for scleral lens fitting i.e. corneal protection, 
tear conservation, or pain relief.
Success rate
Development of scleral lenses with a smoother continuous 
back surface that follows more precisely the underlying 
scleral surface has made prolonged, comfortable scleral 
lens wear possible. Penetration of liquids under the lens in 
situ, i.e. positive Á uid-venting was found to be associated 
with successful À t and increased wearing time.
Moreover, the combination of high oxygen permeability 
and favorable tear exchange allowed by the lens back 
geometry may diminish the incidence of complications such 
as corneal edema or lens adhesion.
Failure rates during the period of our study were 21 %. 
This number concurs with the results of other investigations. 
In a retrospective study, Tan et al. 20 found that 71 % of the 
eyes could continue wearing the scleral lens, Pullum and 
Buckley 16 described that 22 % of their cases failed a scleral 
trial or stopped wearing their scleral lenses completely. 
Failure rate of 10.4 % was reported by Segal et al.,5 while 
Schornack and Patel 21 reported that 12 out of 32 patients 
(38 %) decided not to pursue scleral lens wear after initial 
evaluation.
In conclusion, modern scleral contact lenses can be used 
successfully for visual rehabilitation and management of a 
wide range of corneal disorders that have not responded 
adequately to other treatments. The main indication for 
GP-SCL is optical correction of an irregular corneal surface, 
especially due to keratoconus and post corneal transplant. 
In the keratoconus group, GP-SCL serves as an alternative 
to surgery. In the post-PKP group GP-SCL provided an 
alternative to refractive surgery or repeated corneal 
transplantation. Scleral lenses were found beneficial in 
several forms of ocular surface diseases. Therapeutic 
benefits of GP-SCL enhance the management of ocular 
surface diseases when medical treatments have failed and 
surgery is undesirable.
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